Cognitive effects of adjunctive perampanel in patients with refractory epilepsy: an open-label, comparative study
Latest Information Update: 02 Mar 2020
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 01 Mar 2020 Status changed from to discontinued.
- 05 Dec 2016 New trial record